Craneware PLC (AIM:CRW) shares plunged 25% to 1006p on Monday after the healthcare software group reset its near-term expectations, prompting Peel Hunt to slash profit forecasts and place its rating and target price under review. The sell-off followed Craneware's full-year results, in which it reset revenue expectations for the year to June 2027 to around US$185 million, broadly equivalent to i...
Craneware PLC (AIM:CRW) has reset its revenue expectations for the current financial year to around $185 million following a cyber security incident, despite reporting higher profit and improved margins for the year to June 30, 2026. The US healthcare software specialist said the immediate impact of the July cyber incident had been contained, with no disruption to customer services or core oper...
Craneware PLC (AIM:CRW) has disclosed a cyber security incident in which hackers gained unauthorised access to part of its data environment and stole employee, customer and partner records. The Edinburgh-based healthcare financial performance software firm said a significant volume of file names were viewed and taken, though its current assessment is that much of the data involved is non-sensit...
Craneware PLC (AIM:CRW) shares slumped 18%, trading down to 1,192p, after the firm warned full-year revenue and earnings will fall below market expectations after 340B pharmacy-related opportunities converted into recognised revenue more slowly than anticipated in the final weeks of the financial year. The healthcare financial performance software group said revenue for the year to 30 June 2026...
The Sage Group PLC (LSE:SGE), Craneware PLC (AIM:CRW) and Cerillion PLC (AIM:CER) are trading at valuations last seen between 2010 and 2014, and Peel Hunt reckons the market has confused two very different things: coding and software. That is the sharp end of a new thematic research note from the broker's AI team.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.